Long-term dietary (n-3) polyunsaturated fatty acids show benefits to the lungs of Cftr F508del mice

PLoS One. 2018 Jun 1;13(6):e0197808. doi: 10.1371/journal.pone.0197808. eCollection 2018.

Abstract

Introduction: The pro-inflammatory status of cystic fibrosis (CF) patients promotes pulmonary colonization with opportunist and pathogenic bacteria, which is favored by a sticky mucus. Oral supplementation with (n-3) long chain polyunsaturated fatty acids (LC-PUFA) has shown anti-inflammatory effects. The aim of this study was to demonstrate the positive effects of a long-term diet enriched in (n-3) LC-PUFA on the lungs of Cftr F508del mice.

Materials and methods: Breeding CftrΔF508del/+ mice received a control diet or a diet enriched in (n-3) LC-PUFA for 5 weeks before mating, gestation and lactation. After weaning, the offspring were given the same diet as their mother until post-natal day 60. The effects of (n-3) LC-PUFA supplementation on the lungs were evaluated in homozygous Cftr F508del mice and their wild-type littermates after acute lung inflammation induced by Pseudomonas aeruginosa lipopolysaccharide (LPS) inhalation.

Results: (n-3) LC-PUFA enrichment of mothers contributes to enrichment of mammary milk and cell membrane of suckling pups. Cftr F508del mice exhibited growth retardation and lung damage with collapsed alveoli, hyperplasia of bronchial epithelial cells and inflammatory cell infiltration. The (n-3) LC-PUFA diet corrected the growth delay of Cftr F508del mice and decreased hyperplasia of bronchial epithelial cells. Besides decreasing metaplasia of Club cells after LPS inhalation, (n-3) LC-PUFA modulated lung inflammation and restricted lung damage.

Conclusion: Long-term (n-3) LC-PUFA supplementation shows moderate benefits to the lungs of Cftr F508del mice.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Biological Transport
  • Diet*
  • Dietary Supplements
  • Fatty Acids, Omega-3 / metabolism
  • Fatty Acids, Omega-3 / pharmacology*
  • Female
  • Growth and Development / drug effects
  • Lung / cytology
  • Lung / drug effects*
  • Lung / metabolism
  • Male
  • Mice
  • Time Factors

Substances

  • Fatty Acids, Omega-3

Grants and funding

This work was supported by the French Cystic Fibrosis Association “Vaincre la Mucoviscidose” and the French Foundation on Digestive Tract Diseases and Nutrition “DigestScience”. C.P. is the recipient of a Université Lille 2 fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.